Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form

被引:159
作者
Nelp, Micah T. [1 ]
Kates, Patrick A. [1 ]
Hunt, John T. [2 ]
Newitt, John A. [3 ]
Balog, Aaron [4 ]
Maley, Derrick [2 ]
Zhu, Xiao [3 ]
Abell, Lynn [5 ]
Allentoff, Alban [6 ]
Borzilleri, Robert [4 ]
Lewis, Hal A. [3 ]
Lin, Zeyu [5 ]
Seitz, Steven P. [4 ]
Yan, Chunhong [3 ]
Groves, John T. [1 ]
机构
[1] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA
[2] Bristol Myers Squibb Co, Immunooncol Biol, Princeton, NJ 08543 USA
[3] Bristol Myers Squibb Co, Mol Discovery Technol, Princeton, NJ 08543 USA
[4] Bristol Myers Squibb Co, Dept Discovery Chem, Princeton, NJ 08543 USA
[5] Bristol Myers Squibb Co, Leads Discovery & Optimizat, Princeton, NJ 08543 USA
[6] Bristol Myers Squibb Co, Dept Radiochem, Princeton, NJ 08543 USA
关键词
IDO1; heme; cancer; kynurenine; SOLUBLE GUANYLYL CYCLASE; 1; IDO1; INHIBITORS; TRYPTOPHAN CATABOLISM; CELL-PROLIFERATION; HEME; MECHANISM; INFLAMMATION; DIOXYGENASE; DISCOVERY; BINDING;
D O I
10.1073/pnas.1719190115
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
For cancer cells to survive and proliferate, they must escape normal immune destruction. One mechanism by which this is accomplished is through immune suppression effected by up-regulation of indoleamine 2,3-dioxygenase (IDO1), a heme enzyme that catalyzes the oxidation of tryptophan to N-formylkynurenine. On deformylation, kynurenine and downstream metabolites suppress T cell function. The importance of this immunosuppressive mechanism has spurred intense interest in the development of clinical IDO1 inhibitors. Herein, we describe the mechanism by which a class of compounds effectively and specifically inhibits IDO1 by targeting its apoform. We show that the in vitro kinetics of inhibition coincide with an unusually high rate of intrinsic enzyme-heme dissociation, especially in the ferric form. X-ray crystal structures of the inhibitor-enzyme complexes show that heme is displaced from the enzyme and blocked from rebinding by these compounds. The results reveal that apo-IDO1 serves as a unique target for inhibition and that heme lability plays an important role in posttranslational regulation.
引用
收藏
页码:3249 / 3254
页数:6
相关论文
共 52 条
[31]   IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance [J].
Munn, David H. ;
Mellor, Andrew L. .
TRENDS IN IMMUNOLOGY, 2016, 37 (03) :193-207
[32]   Indoleamine 2,3 dioxygenase and metabolic control of immune responses [J].
Munn, David H. ;
Mellor, Andrew L. .
TRENDS IN IMMUNOLOGY, 2013, 34 (03) :137-143
[33]   Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase [J].
Munn, DH ;
Sharma, MD ;
Lee, JR ;
Jhaver, KG ;
Johnson, TS ;
Keskin, DB ;
Marshall, B ;
Chandler, P ;
Antonia, SJ ;
Burgess, R ;
Slingluff, CL ;
Mellor, AL .
SCIENCE, 2002, 297 (5588) :1867-1870
[34]   Prevention of allogeneic fetal rejection by tryptophan catabolism [J].
Munn, DH ;
Zhou, M ;
Attwood, JT ;
Bondarev, I ;
Conway, SJ ;
Marshall, B ;
Brown, C ;
Mellor, AL .
SCIENCE, 1998, 281 (5380) :1191-1193
[35]   Inhibition of T cell proliferation by macrophage tryptophan catabolism [J].
Munn, DH ;
Shafizadeh, E ;
Attwood, JT ;
Bondarev, I ;
Pashine, A ;
Mellor, AL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (09) :1363-1372
[36]   Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite [J].
Platten, M ;
Ho, PP ;
Youssef, S ;
Fontoura, P ;
Garren, H ;
Hur, EM ;
Gupta, R ;
Lee, LY ;
Kidd, BA ;
Robinson, WH ;
Sobel, RA ;
Selley, ML ;
Steinman, L .
SCIENCE, 2005, 310 (5749) :850-855
[37]   Discovery of IDO1 Inhibitors: From Bench to Bedside [J].
Prendergast, George C. ;
Malachowski, William P. ;
DuHadaway, James B. ;
Muller, Alexander J. .
CANCER RESEARCH, 2017, 77 (24) :6795-6811
[38]   Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors [J].
Roehrig, Ute F. ;
Majjigapu, Somi Reddy ;
Vogel, Pierre ;
Zoete, Vincent ;
Michiein, Olivier .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (24) :9421-9437
[39]   Interactions between Nitric Oxide and Indoleamine 2,3-dioxygenase [J].
Samelson-Jones, Ben J. ;
Yeh, Syun-Ru .
BIOCHEMISTRY, 2006, 45 (28) :8527-8538
[40]  
SONO M, 1980, J BIOL CHEM, V255, P1339